ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Colorado » Ophthalmology

Top Ophthalmology Prescribers in Colorado

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EARL CRAVEN MD

Ophthalmology

3,919

$376K

698
637 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

66%
prescriptions for brand name drugs

Avg: 59%

$96
Average prescription price

Avg: $69

CAROLYN QUINN M.D.

Ophthalmology

3,893

$270K

606
578 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

61%
prescriptions for brand name drugs

Avg: 59%

$69
Average prescription price

Avg: $69

ERIC BLOM M.D.

Ophthalmology

3,734

$173K

586
504 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

42%
prescriptions for brand name drugs

Avg: 59%

$46
Average prescription price

Avg: $69

TODD MAUS MD

Ophthalmology

3,227

$141K

672
649 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 59%

$44
Average prescription price

Avg: $69

JOHN SAMPLES

Ophthalmology

3,135

$317K

502
459 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

72%
prescriptions for brand name drugs

Avg: 59%

$101
Average prescription price

Avg: $69

PAUL RASTRELLI M.D.

Ophthalmology

3,060

$154K

665
574 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

46%
prescriptions for brand name drugs

Avg: 59%

$50
Average prescription price

Avg: $69

WALTER HOFFMAN M.D.

Ophthalmology

2,966

$244K

581
551 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

71%
prescriptions for brand name drugs

Avg: 59%

$82
Average prescription price

Avg: $69

RICHARD STIVERSON

Ophthalmology

2,931

$112K

640
618 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

51%
prescriptions for brand name drugs

Avg: 59%

$38
Average prescription price

Avg: $69

WILLIAM SELF MD

Ophthalmology

2,907

$162K

698
628 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

55%
prescriptions for brand name drugs

Avg: 59%

$56
Average prescription price

Avg: $69

KENT BASHFORD DO

Ophthalmology

2,842

$237K

491
442 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

70%
prescriptions for brand name drugs

Avg: 59%

$83
Average prescription price

Avg: $69

JOSHUA ZASTROCKY M.D.

Ophthalmology

2,557

$129K

412
381 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

38%
prescriptions for brand name drugs

Avg: 59%

$51
Average prescription price

Avg: $69

VIRGINIA KLAIR M.D.

Ophthalmology

2,365

$128K

502
448 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

53%
prescriptions for brand name drugs

Avg: 59%

$54
Average prescription price

Avg: $69

CHESTER ROE M.D.

Ophthalmology

2,293

$160K

308
285 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

68%
prescriptions for brand name drugs

Avg: 59%

$70
Average prescription price

Avg: $69

GARY FOSTER M.D.

Ophthalmology

2,289

$258K

568
528 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

93%
prescriptions for brand name drugs

Avg: 59%

$113
Average prescription price

Avg: $69

JOHN KIRK M.D.

Ophthalmology

2,266

$151K

438
407 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

59%
prescriptions for brand name drugs

Avg: 59%

$67
Average prescription price

Avg: $69

BRADLEY SCHUSTER MD

Ophthalmology

2,150

$96.1K

439
415 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

39%
prescriptions for brand name drugs

Avg: 59%

$45
Average prescription price

Avg: $69

LEE SCHELONKA M.D

Ophthalmology

2,080

$83.5K

485
464 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

46%
prescriptions for brand name drugs

Avg: 59%

$40
Average prescription price

Avg: $69

JOHN KLOOR

Ophthalmology

2,011

$99.4K

604
570 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

59%
prescriptions for brand name drugs

Avg: 59%

$49
Average prescription price

Avg: $69

THOMAS WESCOM M.D.

Ophthalmology

1,999

$65.7K

423
410 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

46%
prescriptions for brand name drugs

Avg: 59%

$33
Average prescription price

Avg: $69

MINA PANTCHEVA MD

Ophthalmology

1,987

$168K

309
237 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

61%
prescriptions for brand name drugs

Avg: 59%

$85
Average prescription price

Avg: $69

DEAN CARLSON M.D.

Ophthalmology

1,960

$118K

328
303 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

57%
prescriptions for brand name drugs

Avg: 59%

$60
Average prescription price

Avg: $69

MICAH ROTHSTEIN M.D.

Ophthalmology

1,929

$171K

361
332 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

69%
prescriptions for brand name drugs

Avg: 59%

$89
Average prescription price

Avg: $69

JERRY BUSH MD

Ophthalmology

1,889

$121K

352
330 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

53%
prescriptions for brand name drugs

Avg: 59%

$64
Average prescription price

Avg: $69

MICHAEL COATNEY D.O.

Ophthalmology

1,846

$76.9K

474
417 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

20%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

47%
prescriptions for brand name drugs

Avg: 59%

$42
Average prescription price

Avg: $69

RANDALL ROTTMAN MD

Ophthalmology

1,833

$106K

364
322 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

64%
prescriptions for brand name drugs

Avg: 59%

$58
Average prescription price

Avg: $69

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank